Stevanato Group (NYSE:STVN - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.530-0.570 for the period. The company issued revenue guidance of $1.2 billion-$1.3 billion.
Stevanato Group Stock Down 2.9%
NYSE:STVN traded down €0.70 ($0.81) during trading hours on Friday, hitting €23.50 ($27.33). The company's stock had a trading volume of 364,300 shares, compared to its average volume of 374,159. The stock has a market capitalization of $7.12 billion, a P/E ratio of 43.52, a price-to-earnings-growth ratio of 2.38 and a beta of 0.55. The stock has a fifty day moving average of €24.52 and a 200-day moving average of €22.44. The company has a current ratio of 1.79, a quick ratio of 1.26 and a debt-to-equity ratio of 0.25. Stevanato Group has a 52-week low of €17.12 ($19.91) and a 52-week high of €28.00 ($32.56).
Analyst Ratings Changes
Several equities analysts have issued reports on the company. Stephens raised Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of €25.13 ($29.22).
Check Out Our Latest Stock Report on Stevanato Group
Hedge Funds Weigh In On Stevanato Group
An institutional investor recently raised its position in Stevanato Group stock. Royal Bank of Canada boosted its position in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 10.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 437,284 shares of the company's stock after purchasing an additional 42,731 shares during the period. Royal Bank of Canada owned about 0.14% of Stevanato Group worth $8,930,000 as of its most recent filing with the Securities & Exchange Commission.
Stevanato Group Company Profile
(
Get Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
See Also

Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.